BGI MGI Tech Heads Full Steam Into US Market Despite Data Security Accusations, Image Problems Premium The Chinese sequencing instrument maker, affiliated with BGI Group, plans to roll out a plethora of platforms in the US next year, targeting various market needs. BGI Group Vows to Sue Ex-Business Partner for Defamation BGI Group said it will take legal action against Deming Wang, who has repeatedly alleged BGI Genomics’ PCR tests are inaccurate, causing the firm's stock to drop. In Brief This Week: Biocept, Thermo Fisher, Biodesix, More News items for the week of Nov. 21, 2022. In Brief This Week: Pacific Biosciences, Pierian, PerkinElmer, Ginkgo Bioworks, More News items for the week of Oct. 17, 2022. MGI Tech Q3 Revenues Rise 5 Percent Premium The Chinese sequencing tech company also reported a net profit of RMB 1.68 billion for the quarter, driven by a recent settlement payment from Illumina. Oct 7, 2022 US Department of Defense Adds BGI Genomics to Blacklist of 'Chinese Military Companies' Sep 27, 2022 MGI Tech Launches New Ultra-High-Speed, Mid-to-Low Throughput Sequencer Premium Sep 2, 2022 BGI Gets CE-IVD Mark for Thalassemia Test Aug 29, 2022 MGI Tech Planning to go Public in $366M Chinese IPO Jul 7, 2022 MGI Tech, Illumina Reach Agreement in UK Sequencing IP Lawsuit, Enabling Launch of HotMPS Chemistry Jun 17, 2022 Single-Nucleus Sequencing Analysis Generates Cell Atlas of Ant Superorganism Brains Jun 13, 2022 MGI Aims to Reenter European Sequencing Market With New HotMPS Chemistry Premium Jun 10, 2022 New Sequencing Companies Raise Hopes, Eyebrows at AGBT Premium Jun 7, 2022 MiRxes, BGI Research, MGI Partner on Spatial Genomics in Singapore Jun 6, 2022 MGI to Take Another Crack at US Next-Gen Sequencing Market This Summer Premium May 5, 2022 BGI Fosters Adoption of Stereo-Seq Spatial Transcriptomics Technology Premium Apr 29, 2022 New Products Posted to GenomeWeb: MGI, Tecan, Qiagen, More Apr 13, 2022 Non-Human Primate Single-Cell Transcriptomic Atlas Presented by BGI-led Team Apr 1, 2022 Genomic Answers for Kids Project Advances Long-Read Sequencing for Rare Disease Testing Premium Mar 28, 2022 Court Grants Illumina Permanent Injunction Against BGI, Blocking Sale of Products in US Mar 8, 2022 Multiomic Analyses Point to Organ-Specific Biological Aging Patterns Jan 14, 2022 In Brief This Week: BGI, Gencove, Cepheid, Biocartis, Biognosys, Co-Diagnostics, More Jan 4, 2022 Chinese Study Uncovers Ties Between Blood Metabolites, Gut Microbes Dec 1, 2021 Illumina Wins $8M Jury Verdict in BGI Patent Infringement Suit, Loses Patent Oct 28, 2021 BGI Genomics Program Seeks to Validate Signatera Test for Colorectal Cancer Patients in China Premium Load More Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.